Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Anti-Neoplastic Agents Market Size Shifted, And What Is the Outlook Through 2034?
The market for anti-neoplastic agents has been witnessing robust growth in recent years. It is projected to expand from $130.01 billion in 2024 to $140.9 billion in 2025, marking a compound annual growth rate (CAGR) of 8.4%. Factors contributing to the growth trend in the past have been a rise in the prevalence of cancer, increasing demand for treatments, escalating preference for minimally invasive procedures in cancer therapy, and the necessity for cost-effective anti-neoplastic treatment options.
The market for anti-neoplastic agents is projected to experience robust growth over the coming years, with an expected valuation of $197.68 billion by 2029, fueled by a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this projected expansion during the predicted period include increased patient education and awareness, government initiatives, a rising demand for individualized cancer therapies, and a heightened emphasis on the quality of life during cancer treatment. Key trends to watch for during the forecast period encompass progress in oncology research, the creation of targeted therapies, innovations in biotechnology, and advancements in diagnostic tools.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12901&type=smp
What are the Fundamental Drivers and Innovations Shaping the Anti-Neoplastic Agents Market?
The rising incidence of cancer is likely to fuel the expansion of the antineoplastic agent market. Essentially, cancer is a collection of diseases with the potential to occur in virtually any organ or tissue when rogue cells proliferate uncontrollably, exceed their usual boundaries, and either metastasize to other organs or infiltrate adjacent body parts. Antineoplastic agents are vital in combating cancer, limiting the growth and division of cancerous cells through multiple strategies, such as causing DNA damage, hindering the cell cycle, and disrupting crucial cellular pathways. For example, the International Agency for Research on Cancer (IARC), based in France and dedicated to fostering international cooperation in cancer research, reported in February 2024 that the cancer burden is anticipated to rise to over 35 million by 2050, marking a 77% increase from the estimated 20 million in 2022. Therefore, the sharp rise in cancer diagnoses is propelling the antineoplastic agent market’s expansion.
How Is the Anti-Neoplastic Agents Market Segmented?
The anti-neoplastic agents market covered in this report is segmented –
1) By Type: Alkylating Agents, Antimetabolites, Hormones And Antagonists, Miscellaneous
2) By Disease Type: Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Other Disease Types
3) By End User: Hospitals, Clinics, Cancer Rehabilitation Centers, Ambulatory Surgical Centers
Subsegments:
1) By Alkylating Agents: Nitrogen Mustards, Alkyl Sulfonates, Nitrosoureas, Triazines
2) By Antimetabolites: Purine Analogues, Pyrimidine Analogues, Folate Antagonists
3) By Hormones and Antagonists: Estrogens and Antiestrogens, Androgens and Antiandrogens, Glucocorticoids
4) By Miscellaneous: Vinca Alkaloids, Taxanes, Antibiotic Antineoplastics, Targeted Therapy Agents
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12901&type=smp
Which Regions Are Driving the Next Phase of the Anti-Neoplastic Agents Market Growth?
North America was the largest region in the anti-neoplastic agents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anti-neoplastic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Key Trends Are Shaping the Future of the Anti-Neoplastic Agents Market?
Leading firms in the anti-neoplastic agent market are striving to innovate clinical methods to maintain their market standing. For instance, Novartis AG, a pharmaceutical corporation based in Switzerland, declared in March 2022 that it received the Food and Drug Administration’s (FDA) approval for Pluvicto, which is the first-ever targeted radioligand treatment for progressive, PSMA positive metastatic castration-resistant prostate cancer (mCRPC). It is advised to administer 7.4 GBq (200 mCi) of Pluvicto intravenously every six weeks, up to a maximum of six doses, or until the disease progression becomes unbearable or toxicity levels peak. The selection of patients with previously treated mCRPC for treatment with Pluvicto should be based on the expression of PSMA in tumors, using Locametz or another authorized PSMA-11 imaging agent.
View the full report here:
https://www.thebusinessresearchcompany.com/report/anti-neoplastic-agents-global-market-report
How Is the Anti-Neoplastic Agents Market Defined and What Are Its Core Parameters?
Anti-neoplastic agents refer to drugs that inhibit or destroy abnormal tissue growth, specifically targeting and combating cancerous cells in the body. They have a vital role in cancer treatment by disrupting the processes involved in tumor development and progression.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12901
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model